Fig. 3From: Survival outcome of different treatment sequences in patients with locally advanced and metastatic pancreatic cancerSubgroup analysis by forest plot, with HRs for OS, in the patients treated with A line and B line. Abbreviations: ECOG, Eastern Cooperative Oncology Group performance scale; A line, NabP/Gem or NabP combined therapy to FOLFIRINOX; B line, NabP combined therapy to Gem combined therapy to FOLFIRINOXBack to article page